Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Erratum to "the comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia".

Dehghani SM, Imanieh MH, Oboodi R, Haghighat M.

ISRN Pediatr. 2013 Mar 28;2013:206546. doi: 10.1155/2013/206546. Print 2013. No abstract available.

2.

The comparative study of the effectiveness of cimetidine, ranitidine, famotidine, and omeprazole in treatment of children with dyspepsia.

Dehghani SM, Imanieh MH, Oboodi R, Haghighat M.

ISRN Pediatr. 2011;2011:219287. doi: 10.5402/2011/219287. Epub 2011 Apr 5. Erratum in: ISRN Pediatr. 2013;2013:206546.

3.

Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.

Saha N, Sachdev A, Bhasin DK, Sankaranahyanan A, Khosla PP, Singh K, Sharma PL.

Int J Clin Pharmacol Ther Toxicol. 1993 Jul;31(7):322-5.

PMID:
8103763
4.

Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.

Francavilla A, Panella C, Polimeno L, Di Leo A, Makowka L, Barone M, Amoruso A, Ingrosso M, Starzl TE.

J Hepatol. 1989 Jan;8(1):32-41.

5.
6.

[Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].

Maculotti L, Pradella P.

Minerva Chir. 1995 Mar;50(3):279-81. Italian.

PMID:
7659265
7.
9.

Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.

Merki HS, Witzel L, Walt RP, Neumann J, Scheurle E, Mappes A, Krammisch H, Heim J, Kaufmann D, Roehmel J.

Gut. 1988 Jan;29(1):81-4.

10.

Comparison of famotidine with cimetidine and ranitidine.

Berardi RR, Tankanow RM, Nostrant TT.

Clin Pharm. 1988 Apr;7(4):271-84. Review.

PMID:
2896559
11.

Famotidine, a new, potent, long-acting histamine H2-receptor antagonist: comparison with cimetidine and ranitidine in the treatment of Zollinger-Ellison syndrome.

Howard JM, Chremos AN, Collen MJ, McArthur KE, Cherner JA, Maton PN, Ciarleglio CA, Cornelius MJ, Gardner JD, Jensen RT.

Gastroenterology. 1985 Apr;88(4):1026-33.

PMID:
2857672
12.

Famotidine in the therapy of gastric hypersecretory states.

Vinayek R, Howard JM, Maton PN, Wank SA, Slaff JI, Gardner JD, Jensen RT.

Am J Med. 1986 Oct 24;81(4B):49-59.

PMID:
2877575
13.

Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.

Amsden GW, Goss TF, Harrison NJ, D'Andrea DT, Schentag JJ.

J Clin Pharmacol. 1994 Dec;34(12):1191-8.

PMID:
7738215
14.

Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery.

Escolano F, Castaño J, López R, Bisbe E, Alcón A.

Br J Anaesth. 1992 Oct;69(4):404-6.

PMID:
1419452
16.

Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.

Decktor DL, Pendleton RG, Kellner AT, Davis MA.

J Pharmacol Exp Ther. 1989 Apr;249(1):1-5.

PMID:
2565384
17.

The effects of cimetidine, ranitidine, and famotidine on human neutrophil functions.

Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y.

Anesth Analg. 1999 Jul;89(1):218-24.

PMID:
10389808
18.

Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells.

Hahm KB, Park IS, Kim HC, Lee KJ, Kim JH, Cho SW, Lee SI.

Int J Immunopharmacol. 1996 Jun-Jul;18(6-7):393-9.

PMID:
9024941
19.

Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.

Ahmadi A, Ebrahimzadeh MA, Ahmad-Ashrafi S, Karami M, Mahdavi MR, Saravi SS.

Fundam Clin Pharmacol. 2011 Feb;25(1):72-9. doi: 10.1111/j.1472-8206.2009.00810.x.

PMID:
20070855
Items per page

Supplemental Content

Write to the Help Desk